Recent research published in The American Journal of Psychiatry showcases the use of Cambridge Cognition’s Cantab product in two phase 3 clinical trials involving patients with schizophrenia. Cobenfy, ...
The failure in mid-October of Cantab's (Cambridge, UK) lead vaccine TH-GW for the treatment of genital warts knocked more than two-thirds off the company's share price, forcing the resignation of ...
This approach reduces both the positive and negative symptoms of schizophrenia more effectively 2. CANTAB digital assessments provide accurate and objective measures of cognitive function in clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback